KDIGO急性腎損傷指南解讀_第1頁
KDIGO急性腎損傷指南解讀_第2頁
KDIGO急性腎損傷指南解讀_第3頁
KDIGO急性腎損傷指南解讀_第4頁
KDIGO急性腎損傷指南解讀_第5頁
已閱讀5頁,還剩30頁未讀 繼續(xù)免費閱讀

下載本文檔

版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領

文檔簡介

KDIGO急性腎損傷指南解讀1精選pptKDIGOClinicalPracticeGuidelineforAcuteKidneyInjuryKidneyinter.Suppl.2021;2:1–1382精選pptGRADE系統(tǒng)3精選ppt總推薦條目87條未分級26條29.9%2級39條63.9%1級22條36.1%1A:914.8%1B:1016.4%1C:34.9%2A:23.3%2B:1016.4%2C:2032.8%2D:711.5%4精選ppt內(nèi)容IntroductionandMethodologyAKIDefinitionPreventionandTreatmentofAKIContrast-inducedAKIDialysisInterventionsforTreatmentofAKI5精選ppt符合以下任何一條即可診斷1.IncreaseinSCrby≥0.3mg/dl(≥26.5lmol/l)within48hours2.IncreaseinSCrto≥1.5timesbaseline,whichisknownorpresumedtohaveoccurredwithintheprior7days3.Urinevolume<0.5ml/kg/hfor6hours.AKI診斷(NotGraded)6精選pptStageSerumcreatinineUrineoutput11.5–1.9timesbaselineOR<0.5ml/kg/hfor≥0.3mg/dl(≥26.5mmol/l)increase6–12hours22.0–2.9timesbaseline<0.5ml/kg/hfor≥12hours33.0timesbaselineORIncreaseinserumcreatinineto<0.3ml/kg/hfor

≥4.0mg/dl(≥353.6mmol/l)≥24hoursORORInitiationofrenalreplacementtherapyAnuriafor≥12hoursOR,Inpatients<18years,decreaseineGFRto<35ml/minper1.73m2AKI分級(NotGraded)7精選pptThecauseofAKIshouldbedeterminedwheneverpossible.(NotGraded)SelectedcausesofAKIrequiringimmediatediagnosisandspecifictherapiesRecommendeddiagnostictestsDecreasedkidneyperfusionVolumestatusandurinarydiagnosticindicesAcuteglomerulonephritis,vasculitis,Urinesedimentexamination,interstitialnephritis,thromboticserologictestingandMicroangiopathyhematologictesting

UrinarytractobstructionKidneyultrasound8精選pptWerecommendthatpatientsbestratifiedforriskofAKIaccordingtotheirsusceptibilitiesandexposures.(1B)ManagepatientsaccordingtotheirsusceptibilitiesandexposurestoreducetheriskofAKI.(NotGraded)TestpatientsatincreasedriskforAKIwithmeasurementsofSCrandurineoutputtodetectAKI.(NotGraded)Individualizefrequencyanddurationofmonitoringbasedonpatientriskandclinicalcourse.(NotGraded)9精選pptExposuresSusceptibilitiesSepsisDehydrationorvolumedepletionCriticalillnessAdvancedageCirculatoryshockFemalegenderBurnsBlackraceTraumaCKDCardiacsurgery(especiallyChronicdiseases(heart,lung,liver)withCPB)MajornoncardiacsurgeryDiabetesmellitusNephrotoxicdrugsCancerRadiocontrastagentsAnemiaPoisonousplantsandanimalsCausesofAKI:exposuresandsusceptibilitiesfornon-specificAKI10精選pptEvaluatepatientswithAKIpromptlytodeterminethecause,withspecialattentiontoreversiblecauses.(NotGraded)MonitorpatientswithAKIwithmeasurementsofSCrandurineoutputtostagetheseverity,accordingtoRecommendation.(NotGraded)ManagepatientswithAKIaccordingtothestageandcause.(NotGraded)11精選ppt12精選ppt13精選pptAKI時RRT治療時機InitiateRRTemergentlywhenlife-threateningchangesinfluid,electrolyte,andacid-basebalanceexist.(NotGraded)Considerthebroaderclinicalcontext,thepresenceofconditionsthatcanbemodifiedwithRRT,andtrendsoflaboratorytests—ratherthansingleBUNandcreatininethresholdsalone—whenmakingthedecisiontostartRRT.(NotGraded)14精選pptPotentialapplicationsforRRTApplicationsCommentsRenalreplacementThisisthetraditional,prevailingapproachbasedonutilizationofRRTwhenthereislittleornoresidualkidneyfunction.Life-threateningindicationsNotrialstovalidatethesecriteria.HyperkalemiaDialysisforhyperkalemiaiseffectiveinremovingpotassium;however,itrequiresfrequentmonitoringofpotassiumlevelsandadjustmentofconcurrentmedicalmanagementtopreventrelapses.AcidemiaMetabolicacidosisduetoAKIisoftenaggravatedbytheunderlyingcondition.CorrectionofmetabolicacidosiswithRRTintheseconditionsdependsontheunderlyingdiseaseprocess.PulmonaryedemaRRTisoftenutilizedtopreventtheneedforventilatorysupport;however,itisequallyimportanttomanagepulmonaryedemainventilatedpatients.Uremiccomplications(pericarditis,bleeding,etc.)IncontemporarypracticeitisraretowaittoinitiateRRTinAKIpatientsuntilthereareuremiccomplications15精選pptPotentialapplicationsforRRTApplicationsCommentsNonemergentindicationsSolutecontrolBUNreflectsfactorsnotdirectlyassociatedwithkidneyfunction,suchascatabolicrateandvolumestatus.SCrisinfluencedbyage,race,musclemass,andcatabolicrate,andbychangesinitsvolumeofdistributionduetofluidadministrationorwithdrawal.FluidremovalFluidoverloadisanimportantdeterminantofthetimingofRRTinitiation.Correctionofacid-baseAbnormalitiesNostandardcriteriaforinitiatingdialysisexist.16精選pptPotentialapplicationsforRRTApplicationsCommentsRenalsupportThisapproachisbasedontheutilizationofRRTtechniquesasanadjuncttoenhancekidneyfunction,modifyfluidbalance,andcontrolsolutelevels.VolumecontrolFluidoverloadisemergingasanimportantfactorassociatedwith,andpossiblycontributingto,adverseoutcomesinAKI.RecentstudieshaveshownpotentialbenefitsfromextracorporealfluidremovalinCHF.Intraoperativefluidremovalusingmodifiedultrafiltrationhasbeenshowntoimproveoutcomesinpediatriccardiacsurgerypatients.NutritionRestrictingvolumeadministrationinthesettingofoliguricAKImayresultinlimitednutritionalsupportandRRTallowsbetternutritionalsupplementation.DrugdeliveryRRTsupportcanenhancestheabilitytoadministerdrugswithoutconcernsaboutconcurrentfluidaccumulation.RegulationofPermissivehypercapnicacidosisinpatientswithlunginjurycanbecorrectedacid-basewithRRT,withoutinducingfluidoverloadandhypernatremia.andelectrolytestatusSoluteChangesinsoluteburdenshouldbeanticipated(e.g.,tumorlysismodulationsyndrome).Althoughcurrentevidenceisunclear,studiesareongoingtoassesstheefficacyofRRTforcytokinemanipulationinsepsis.17精選ppt

AKI時停用RRT指征DiscontinueRRTwhenitisnolongerrequired,eitherbecauseintrinsickidneyfunctionhasrecoveredtothepointthatitisadequatetomeetpatientneeds,orbecauseRRTisnolongerconsistentwiththegoalsofcare.(NotGraded)Wesuggestnotusingdiureticstoenhancekidneyfunctionrecovery,ortoreducethedurationorfrequencyofRRT.(2B)18精選ppt抗凝治療InapatientwithAKIrequiringRRT,basethedecisiontouseanticoagulationforRRTonassessmentofthepatient’spotentialrisksandbenefitsfromanticoagulation.(NotGraded)WerecommendusinganticoagulationduringRRTinAKIifapatientdoesnothaveanincreasedbleedingriskorimpairedcoagulationandisnotalreadyreceivingsystemicanticoagulation.(1B)19精選pptForpatientswithoutanincreasedbleedingriskorimpairedcoagulationandnotalreadyreceivingeffectivesystemicanticoagulation,wesuggestthefollowing:ForanticoagulationinintermittentRRT,werecommendusingeitherunfractionatedorlow-molecular-weightheparin,ratherthanotheranticoagulants.(1C)ForanticoagulationinCRRT,wesuggestusingregionalcitrateanticoagulationratherthanheparininpatientswhodonothavecontraindicationsforcitrate.(2B)ForanticoagulationduringCRRTinpatientswhohavecontraindicationsforcitrate,wesuggestusingeitherunfractionatedorlow-molecular-weightheparin,ratherthanotheranticoagulants.(2C)抗凝治療20精選pptForpatientswithincreasedbleedingriskwhoarenotreceivinganticoagulation,wesuggestthefollowingforanticoagulationduringRRT:Wesuggestusingregionalcitrateanticoagulation,ratherthannoanticoagulation,duringCRRTinapatientwithoutcontraindicationsforcitrate.(2C)WesuggestavoidingregionalheparinizationduringCRRTinapatientwithincreasedriskofbleeding.(2C)抗凝治療21精選pptInapatientwithheparin-inducedthrombocytopenia(HIT),allheparinmustbestoppedandwerecommendusingdirectthrombininhibitors(suchasargatroban)orFactorXainhibitors(suchasdanaparoidorfondaparinux)ratherthanotherornoanticoagulationduringRRT.(1A)InapatientwithHITwhodoesnothavesevereliverfailure,wesuggestusingargatrobanratherthanotherthrombinorFactorXainhibitorsduringRRT.(2C)抗凝治療22精選ppt23精選ppt血管通路WesuggestinitiatingRRTinpatientswithAKIviaanuncuffednontunneleddialysiscatheter,ratherthanatunneledcatheter.(2D)WhenchoosingaveinforinsertionofadialysiscatheterinpatientswithAKI,considerthesepreferences(NotGraded):*Firstchoice:rightjugularvein;*Secondchoice:femoralvein;*Thirdchoice:leftjugularvein;*Lastchoice:subclavianveinwithpreferenceforthedominantside.24精選pptWerecommendusingultrasoundguidancefordialysiscatheterinsertion.(1A)Werecommendobtainingachestradiographpromptlyafterplacementandbeforefirstuseofaninternaljugularorsubclaviandialysiscatheter.(1B)WesuggestnotusingtopicalantibioticsovertheskininsertionsiteofanontunneleddialysiscatheterinICUpatientswithAKIrequiringRRT.(2C)Wesuggestnotusingantibioticlocksforpreventionofcatheter-relatedinfectionsofnontunneleddialysiscathetersinAKIrequiringRRT.(2C)血管通路25精選ppt濾器選擇WesuggesttousedialyzerswithabiocompatiblemembraneforIHDandCRRTinpatientswithAKI.(2C)26精選pptRRT模式選擇UsecontinuousandintermittentRRTascomplementarytherapiesinAKIpatients.(NotGraded)WesuggestusingCRRT,ratherthanstandardintermittentRRT,forhemodynamicallyunstablepatients.(2B)WesuggestusingCRRT,ratherthanintermittentRRT,forAKIpatientswithacutebraininjuryorothercausesofincreasedintracranialpressureorgeneralizedbrainedema.(2B)27精選pptTypicalsettingofdifferentRRTmodalitiesforAKI(for70-kgpatient)28精選pptTheoreticaladvantagesanddisadvantagesofC

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論